C
AbbVie Inc. ABBV
$210.60 $1.100.53% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -31.53% -6.06% -102.68% -12.20% -32.31%
Total Depreciation and Amortization -3.80% -1.69% 1.25% -6.98% -5.71%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 26.72% 154.29% 279.96% 13.17% 45.31%
Change in Net Operating Assets 83.38% -1,144.53% -189.62% -71.45% -710.47%
Cash from Operations 126.90% -59.53% 48.29% -28.08% -64.06%
Capital Expenditure -11.62% -21.76% -41.95% -13.70% -35.39%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -11.51% 94.27% -224.05% -5,309.55% -426.88%
Divestitures -- -- -- -- --
Other Investing Activities 255.56% 733.33% 597.62% 6,842.86% -500.00%
Cash from Investing -7.17% 92.33% -134.25% -2,137.40% -223.17%
Total Debt Issued -- -72.02% -- -- --
Total Debt Repaid -12.13% 40.76% -221.18% -20,050.00% -234.13%
Issuance of Common Stock -50.00% -55.91% -67.74% 86.11% -79.17%
Repurchase of Common Stock -33.33% 27.42% -11,833.33% -325.00% 10.00%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -5.82% -5.52% -4.80% -4.72% -4.76%
Other Financing Activities -- 114.67% 101.75% 150.00% 100.00%
Cash from Financing 55.55% -111.63% -54.21% -15.45% -55.54%
Foreign Exchange rate Adjustments 433.33% 150.00% -300.00% 150.00% 10.00%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 126.17% -106.64% -266.38% -229.70% -341.06%